1. Home
  2. QNRX

QNRX

Quoin Pharmaceuticals Ltd.

Logo Quoin Pharmaceuticals Ltd.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Founded: 2018 Country:
United States
United States
Employees: N/A City: KFAR SABA
Market Cap: 2.6M IPO Year: N/A
Target Price: $4.00 AVG Volume (30 days): 619.9K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -9.64 EPS Growth: N/A
52 Week Low/High: $0.74 - $12.00 Next Earning Date: 05-06-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: